Download
Download eBook for Free
| Format | File Size | Notes |
|---|---|---|
| PDF file | 5.5 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Purchase
Purchase Print Copy
| Format | List Price | Price | |
|---|---|---|---|
| Add to Cart | Paperback142 pages | $15.00 | $12.00 20% Web Discount |
The United States spends over $16 billion a year to fight drugs, or so the Director of the Office of National Drug Control Policy (ONDCP) has certified over the past few years. What confidence is there that this budget accurately reflects federal expenditures on antidrug activities? The agencies that compile the antidrug budgets use a variety of calculation methods, some of which are problematic. Although the drug-control budget will necessarily always be a collection of estimates, it can be significantly improved, by establishing common principles to guide the calculations and by basing them on empirical data. Such steps would provide ONDCP with the ability to implement strategies and hold agencies accountable for their performance. This is essential for the ONDCP Director to be able to direct and coordinate the nation's antidrug programs and for the American people to be confident about what resources are actually being spent on antidrug activities.
Table of Contents
Chapter One
Introduction
Chapter Two
Budgeting Overview
Chapter Three
U.S. Coast Guard
Chapter Four
Federal Bureau of Prisons
Chapter Five
U.S. Department of Defense
Chapter Six
Immigration and Naturalization Service
Chapter Seven
U.S. Customs Service
Chapter Eight
Federal Bureau of Investigation
Chapter Nine
Substance Abuse and Mental Health Services Administration
Chapter Ten
Department of Veterans Affairs
Chapter Eleven
Health Care Financing Administration
Chapter Twelve
U.S. Department of Education
Chapter Thirteen
Conclusions and Recommendations
Research conducted by
The study was conducted within RAND's Science and Technology Division and RAND's Drug Policy Research Center.
This report is part of the RAND Corporation Monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.